CD33 in Alzheimer's Disease

Variants in the ATP-Binding Cassette Transporter (ABCA7), Apolipoprotein E ϵ4, and the Risk of Late-Onset Alzheimer Disease in African Americans

(2013) Christiane Reitz et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology

(2013) Elizabeth M Bradshaw et al.   NATURE NEUROSCIENCE

Functional dissection of CD33 locus implicates innate immune response in Alzheimer disease pathology

(2013) Katy Malpass   Nature Reviews Neurology

Alzheimer’s Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta

(2013) Ana Griciuc et al.   NEURON

Association of GWAS Top Hits With Late-onset Alzheimer Disease in Korean Population

(2012) Sun Ju Chung et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Association of GWAS-linked loci with late-onset Alzheimer's disease in a northern Han Chinese population

(2012) Lan Tan et al.   Alzheimers & Dementia

Siglecs as sensors of self in innate and adaptive immune responses

(2012) James C. Paulson et al.   Annals of the New York Academy of Sciences

High glucose concentrations induce TNF-α production through the down-regulation of CD33 in primary human monocytes

(2012) Yolanda Gonzalez et al.   BMC IMMUNOLOGY

The prevalence of CD33 and MS4A6A variant in Chinese Han population with Alzheimer’s disease

(2012) Yu-Lei Deng et al.   HUMAN GENETICS

The Role of Clusterin in Alzheimer’s Disease: Pathways, Pathogenesis, and Therapy

(2012) Jin-Tai Yu et al.   MOLECULAR NEUROBIOLOGY

Expression of Novel Alzheimer’s Disease Risk Genes in Control and Alzheimer’s Disease Brains

(2012) Celeste M. Karch et al.   PLoS One

Targeting Siglecs—A novel pharmacological strategy for immuno- and glycotherapy

(2011) Camilla Jandus et al.   BIOCHEMICAL PHARMACOLOGY

Antibody-Drug Conjugates of Calicheamicin Derivative: Gemtuzumab Ozogamicin and Inotuzumab Ozogamicin

(2011) A. D. Ricart   CLINICAL CANCER RESEARCH

Replication of EPHA1 and CD33 associations with late-onset Alzheimer's disease: a multi-centre case-control study

(2011) Minerva M Carrasquillo et al.   Molecular Neurodegeneration

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease

(2011) Adam C Naj et al.   NATURE GENETICS

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

(2011) Paul Hollingworth et al.   NATURE GENETICS

Association studies of 19 candidate SNPs with sporadic Alzheimer’s disease in the North Chinese Han population

(2011) Quan Yuan et al.   NEUROLOGICAL SCIENCES

Association and heterogeneity at the GAPDH locus in Alzheimer's disease

(2010) Mariet Allen et al.   NEUROBIOLOGY OF AGING

Decreased Clearance of CNS  -Amyloid in Alzheimer's Disease

(2010) K. G. Mawuenyega et al.   SCIENCE

Basic and Clinical Immunology of Siglecs

(2009) Stephan von Gunten et al.   Annals of the New York Academy of Sciences

Siglec receptors and hiding plaques in Alzheimer's disease

(2009) Antero Salminen et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy

(2009) Guojun Bu   NATURE REVIEWS NEUROSCIENCE

Inflammation, microglia, and alzheimer's disease

(2009) Brent Cameron et al.   NEUROBIOLOGY OF DISEASE

Genome-wide Association Analysis Reveals Putative Alzheimer's Disease Susceptibility Loci in Addition to APOE

(2008) Lars Bertram et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Siglecs as positive and negative regulators of the immune system: Figure 1

(2008) Paul R. Crocker et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

Thematic Review Series: Sphingolipids.Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease—a review,

(2008) Toshio Ariga et al.   JOURNAL OF LIPID RESEARCH